Technology Transfer Branch (TTB) of the National Cancer Institute makes it easy for industry and academia to interact and partner with National Institutes of Health laboratories and scientists. To learn more background information about TTB, choose from the following:
For information about cancer, clinical trials and statistics, please visit http://cancer.gov.
Biomarker to Predict Resistance to Doxorubicin Cancer Therapy
Collaborative Research Opportunity: Treatment of Cocaine Abuse and Other Mental Disorders
Gene-Modified T-Cells: Identification of T-Cell Receptors (TCR)
TTB maintains an e-mail service to notify you of new Collaborative Opportunities. If you would like to receive these emails, please sign up below. If you'd like to unsubscribe you can use this form as well.